| Literature DB >> 33062919 |
Fatemeh Eini1, Khojasteh Joharchi2, Maryam Azizi Kutenaei1, Pegah Mousavi1,3.
Abstract
BACKGROUND: Nigella Sativa (NS) and its active component, thymoquinone, have beneficial protective effects on experimental animal models of polycystic ovary syndrome (PCOS) and different human diseases.Entities:
Keywords: In-vitro maturation; Nigella sativa; Oxidative stress; Polycystic ovary syndrome; Epigenetic modification
Year: 2020 PMID: 33062919 PMCID: PMC7521171 DOI: 10.18502/ijrm.v13i9.7668
Source DB: PubMed Journal: Int J Reprod Biomed ISSN: 2476-3772
Primer sequences
|
| ||||
|
|
|
|
|
|
|
| F:CCTAGTTCCGTGGCTACGAGGAGAA R:TCTCTCTCCTCTGCAGCCGACTCA | NM_010066 | 137 | 58 |
|
| F:CTGAATACAGCAAGCAGATGCAGAG R:TCCCGTGGACAACTGACAGAAC | NM_008228 | 92 | 57 |
|
| F:GAAGTCTTTGGTCTGGTGCCT R:GCTCCTGCTTGAGTATGTCG | NM_011198 | 91 | 60 |
|
| F:CGC TTT CGT ACC ATC GAC ATC R:GGG CCG CCT TAG GAG TTG | NM_001329527 | 77 | 59 |
|
| F:TTGGAGAAGGTACTTACGGTGTGGTG R:CCAGGAGGGATGGAGTCCAGGT | NM_007659 | 89 | 58 |
|
| F:CTGACCCAAACCTCTGTAGTG R:CCTGTATTAGCCAGTCAATGAGG | NM_172301 | 150 | 61 |
|
| F:TTTGCATAGGGAGGTCCAAG R:GGTGCCATCATCAACATCTG | NM_0119449 | 150 | 60 |
|
| F:TGACGTGCCGCCTGGAGAAA R:AGTGTAGCCCAAGATGCCCTTCAG | NM_008084 | 98 | 58 |
The comparision of different concentrations of NSE on oocyte maturation and abnormal morphology between the control and PCOS mice oocytes during in vitro maturation
|
| ||||||
|
|
|
| ||||
|
|
|
|
|
|
| |
|
| 84.93 | 71.38 | 0.025 | 4.51 | 10.57 | 0.012 |
|
| 93.52 | 83.00 | 0.043 | 3.10 | 6.87 | 0.037 |
|
| 93.63 | 86.75 | 0.134 | 2.98 | 3.96 | 0.971 |
|
| 87.08 | 83. 86 | 0.865 | 4.87 | 8.72 | 0.046 |
| MII %: The percentage of mature oocytes; Abnormal morphology %: The percentage of oocyte with abnormal morphology after maturation; NES: Nigella sativa extract; PCOS: Polycystic ovary syndrome. N: number of oocytes. Values are expressed as Mean | ||||||
The effect of different concentrations of NSE on oocyte maturation and abnormal morphology in the control and PCOS mice oocytes during in vitro maturation
|
| ||||
|
|
|
| ||
|
|
|
|
| |
|
| 84.93 | 71.38 | 4.51 | 10.57 |
|
| 93.52 | 83.00 | 3.10 | 6.87 |
|
| 93.63 | 86.75 | 2.98 | 3.96 |
|
| 87.08 | 83. 86 | 4.87 | 8.72 |
| MII %: The percentage of mature oocytes; Abnormal morphology %: The percentage of oocyte with abnormal morphology after maturation; NES: Nigella sativa extract; PCOS: Polycystic ovary syndrome. N: number of oocytes. Values are expressed as Mean | ||||
The comparision of different concentrations of NSE on embryonic development between the control and PCOS mice oocytes during in vitro maturation
|
| ||||||||
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
| |
|
| 78.50 | 68.50 | 66.83 | 55.16 | 49.00 | 40.67 | 42.50 | 30.83 |
|
| 87.50 | 75.16 | 73.17 | 69.83 | 51.66 | 45.00 | 46.33 | 37.00 |
|
| 88.83 | 82.17 | 81.50 | 77.50 | 65.00 | 63.33 | 57.83 | 50.33 |
|
| 76.17 | 71.17 | 69.00 | 59.50 | 48.00 | 44.67 | 42.50 | 37.50 |
| Percentage rates of fertilization, 2-cell, 8-cell, and blastocyst formation of control and PCOS mice oocytes cultured in maturation medium, supplemented with 0, 1, 50, and 100 μg/ml NSE. NES: Nigella sativa extract; PCOS: Polycystic ovary syndrome. Data are presented as Mean | ||||||||
The effect of different concentrations of NSE on embryonic development in the control and PCOS mice oocytes during in vitro maturation
|
| ||||||||
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
| |
|
| 78.50 | 68.50 | 66.83 | 55.16 | 49.00 | 40.67 | 42.50 | 30.83 |
|
| 87.50 | 75.16 | 73.17 | 69.83 | 51.66 | 45.00 | 46.33 | 37.00 |
|
| 88.83 | 82.17 | 81.50 | 77.50 | 65.00 | 63.33 | 57.83 | 50.33 |
|
| 76.17 | 71.17 | 69.00 | 59.50 | 48.00 | 44.67 | 42.50 | 37.50 |
| Percentage rates of fertilization, 2-cell, 8-cell, and blastocyst formation of control and PCOS mice oocytes cultured in maturation medium, supplemented with 0, 1, 50, and 100 μg/ml NSE. NES: Nigella sativa extract; PCOS: Polycystic ovary syndrome. Data are presented as Mean | ||||||||